Clinical Development Reports
Learn how biopharmaceutical and medical device companies establish and justify their clinical investigator FMV rates. This report also provides valuable metrics to build comprehensive clinical trial budgets, plan for likely pass-through or direct costs from trial sites and prepare for upcoming investigator meetings.
Benchmark oncology clinical trials’ key metrics, including cost-drivers, duration, staffing and budgets.
Manage critical Phase I clinical trial cost drivers and prevent expensive delays to move projects through early-stage development.
Harness companion diagnostic metrics to set strategy, improve partner selection and build a program of targeted therapy development.
Explore the next frontier of emerging markets to build a clinical foundation that generates decades of benefits for developers and patients.
Boost trials with Latin America’s untapped clinical promise, including patient availability, established infrastructure, and convenient communication.
Make sense of Europe’s emerging markets to accelerate clinical development and save money while addressing region-specific cultural
challenges in clinical trials.
Navigate the maze of emerging Asian markets to improve patient access and retention while sidestepping clinical teams' common mistakes.
Confidently tap BRIC's potential to deliver patients and lower costs while avoiding the pitfalls common to these new markets.
Chart a comprehensive recruiting and retention strategy with specific tools, processes and resource benchmarks.
Benchmark unit hour costs, project budgets and trial timelines to make the most of your clinical outsourcing strategy.